title: New for old? Risperidone long-acting injection in older patients.
abstract: OBJECTIVE
  To describe six older patients who were treated with risperidone long-acting injection, and to discuss the role of this medication in a psychogeriatric setting.
  
  
  METHODS
  Case series.
  
  
  RESULTS
  Of the six patients trialled on risperidone long-acting injection, two remain on this treatment. Of the other four, three required a change of treatment due to a combination of adverse side-effects and non-response, and one due to adverse side-effects alone.
  
  
  CONCLUSIONS
  Risperidone long-acting injection may have a role to play in the management of older patients with psychotic disorders but further research is required.
authors.affiliation: Nambour Hospital, Nambour, Qld, Australia. pamela_hudson-jessop@health.qld.gov.au
authors.forename: Pamela
authors.initials: P
authors.lastname: Hudson-Jessop
authors.forename: Brendan
authors.initials: B
authors.lastname: Hughes
authors.forename: Neridah
authors.initials: N
authors.lastname: Brinkley
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000453:epidemiology; D003692:Delayed-Action Preparations / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone